These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2076390)

  • 1. Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension.
    Sasaki J; Arakawa K
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1033-5. PubMed ID: 2076390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
    Houston MC; Olafsson L; Burger MC
    Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of captopril on high-density lipoprotein subfractions in patients with mild to moderate essential hypertension.
    Sasaki J; Arakawa K
    Clin Ther; 1989; 11(1):129-34. PubMed ID: 2655902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
    Sasaki J; Koga S; Uzawa H; Arakawa K
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):402-7. PubMed ID: 2676872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM
    Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
    Voorhoof L; Rosseneu M; Caster H; De Keersgieter W
    J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril on serum lipoproteins in mild essential hypertension.
    Sasaki J; Arakawa K
    Clin Ther; 1989; 11(1):38-42. PubMed ID: 2541908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
    Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
    Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild exercise therapy increases serum high density lipoprotein2 cholesterol levels in patients with essential hypertension.
    Sasaki J; Urata H; Tanabe Y; Kinoshita A; Tanaka H; Shindo M; Arakawa K
    Am J Med Sci; 1989 Apr; 297(4):220-3. PubMed ID: 2705460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P; Celis H; Desager JP; Fagard R
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of continuous versus intermittent administration of growth hormone to hypophysectomized female rats on serum lipoproteins and their apoproteins.
    Oscarsson J; Olofsson SO; Bondjers G; Edén S
    Endocrinology; 1989 Sep; 125(3):1638-49. PubMed ID: 2759036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
    Al-Muhtaseb N; Hayat N; Al-Khafaji M
    Atherosclerosis; 1989 Jun; 77(2-3):131-8. PubMed ID: 2751745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.